TP53 and breast carcinoma: In the current study, we injected immunocompetent FVB mice orthotopically with syngeneic p53/PTEN double-null (−/−) primary breast cancer cells into the third mammary fat pad located within the axillary region, and applied daily stretching for four weeks.